Homologous Recombination Deficiency Test Validation in Patients with High-Grade Advanced Ovarian Cancer

Angelica Nogueira Rodrigues, Andreza Karine de Barros Almeida Souto,Diocésio Alves Pinto de Andrade, Larissa Müller Gomes, Sandra Satie Koide, Renata de Godoy E Silva, Bruno Batista de Souza, Juliana Doblas Massaro,Andréia Cristina de Melo, Andrea Morais Borges, Camila Giro, Carlos Augusto Vasconcelos de Andrade, Cesar Martins da Costa,Daniel Luiz Gimenes, Eduardo Caminha Bandeira de Mello, Fernanda Cesar de Oliveira, Frederico Müller de Toledo Lima, Gabriel Lima Lopes, Gustavo de Oliveira Bretas, Gustavo Guerra Jacob, Herika Lucia da Costa Silva, Juliana Ferrari Notaro, Lara Ladislau Alves, Marcos Veloso Moitinho, Mirian Cristina da Silva, Roberto Abramoff, Thais Amaral da Cunha Rauber,Rodrigo Dienstmann,Fernanda Christtanini Koyama

Frontiers in molecular biosciences（2025）

Cited 0|Views1

Key words

ovarian cancer,homologous recombination deficiency,BRCA1/2,validation,next-generation sequencing

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined